These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

105 related items for PubMed ID: 21091771

  • 21. Krüppel-like factor 17 inhibits urokinase plasminogen activator gene expression to suppress cell invasion through the Src/p38/ MAPK signaling pathway in human lung adenocarcionma.
    Cai XD, Che L, Lin JX, Huang S, Li J, Liu XY, Pan XF, Wang QQ, Chen L, Lin MJ, Huang ZH, Ma HM, Wu Y, Liu SM, Zhou YB.
    Oncotarget; 2017 Jun 13; 8(24):38743-38754. PubMed ID: 28454121
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Gonadotropin-releasing hormone (GnRH)-I and GnRH-II induce cell growth inhibition in human endometrial cancer cells: involvement of integrin beta3 and focal adhesion kinase.
    Park DW, Choi KC, MacCalman CD, Leung PC.
    Reprod Biol Endocrinol; 2009 Aug 05; 7():81. PubMed ID: 19656390
    [Abstract] [Full Text] [Related]

  • 27. Suppression of urokinase plasminogen activator receptor inhibits proliferation and migration of pancreatic adenocarcinoma cells via regulation of ERK/p38 signaling.
    Xue A, Xue M, Jackson C, Smith RC.
    Int J Biochem Cell Biol; 2009 Aug 05; 41(8-9):1731-8. PubMed ID: 19433314
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Changes in tenascin-C isoform expression in invasive and preinvasive breast disease.
    Adams M, Jones JL, Walker RA, Pringle JH, Bell SC.
    Cancer Res; 2002 Jun 01; 62(11):3289-97. PubMed ID: 12036947
    [Abstract] [Full Text] [Related]

  • 30. Modulation of phorbol ester-induced regulation of matrix metalloproteinases and tissue inhibitors of metalloproteinases by SB203580, a specific inhibitor of p38 mitogen-activated protein kinase.
    Park MJ, Park IC, Hur JH, Kim MS, Lee HC, Woo SH, Lee KH, Rhee CH, Hong SI, Lee SH.
    J Neurosurg; 2002 Jul 01; 97(1):112-8. PubMed ID: 12134900
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Expression of plasminogen activator inhibitors type 1 and type 3 and urokinase plasminogen activator protein and mRNA in breast cancer.
    Castelló R, Landete JM, España F, Vázquez C, Fuster C, Almenar SM, Ramón LA, Radtke KP, Estellés A.
    Thromb Res; 2007 Jul 01; 120(5):753-62. PubMed ID: 17258797
    [Abstract] [Full Text] [Related]

  • 36. Messenger RNA for urokinase plasminogen activator is expressed in myofibroblasts adjacent to cancer cells in human breast cancer.
    Nielsen BS, Sehested M, Timshel S, Pyke C, Danø K.
    Lab Invest; 1996 Jan 01; 74(1):168-77. PubMed ID: 8569179
    [Abstract] [Full Text] [Related]

  • 37. [Expression and significance of urokinase-type plasminogen activator in breast cancer].
    Xiao J, Zhang G, Xia W.
    Zhonghua Zhong Liu Za Zhi; 1999 May 01; 21(3):196-8. PubMed ID: 11776834
    [Abstract] [Full Text] [Related]

  • 38. uPAR regulates pericellular proteolysis through a mechanism involving integrins and fMLF-receptors.
    Montuori N, Cosimato V, Rinaldi L, Rea VE, Alfano D, Ragno P.
    Thromb Haemost; 2013 Feb 01; 109(2):309-18. PubMed ID: 23238745
    [Abstract] [Full Text] [Related]

  • 39. Extracellular alpha 6 integrin cleavage by urokinase-type plasminogen activator in human prostate cancer.
    Demetriou MC, Pennington ME, Nagle RB, Cress AE.
    Exp Cell Res; 2004 Apr 01; 294(2):550-8. PubMed ID: 15023541
    [Abstract] [Full Text] [Related]

  • 40. Breast cancer cells with inhibition of p38alpha have decreased MMP-9 activity and exhibit decreased bone metastasis in mice.
    Suarez-Cuervo C, Merrell MA, Watson L, Harris KW, Rosenthal EL, Väänänen HK, Selander KS.
    Clin Exp Metastasis; 2004 Apr 01; 21(6):525-33. PubMed ID: 15679050
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.